LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-month TB pill regimen tested for kidney transplant hopefuls
Disease control OngoingThis study tests a 1-month course of three medicines (isoniazid, rifapentine, and vitamin B6) to treat latent tuberculosis in 25 adults with end-stage kidney disease who are candidates for a kidney transplant. The goal is to see if this shorter treatment is safe and easy to compl…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Common TB drug may fuel superbug resistance, study warns
Knowledge-focused OngoingThis study investigates whether taking rifampicin for latent tuberculosis increases the risk of antibiotic resistance in Staphylococcus aureus bacteria that naturally live on the skin. Researchers will compare people treated with rifampicin to those treated with isoniazid, taking…
Matched conditions: LATENT TUBERCULOSIS
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Blood test aims to unmask hidden TB infections before they turn deadly
Knowledge-focused ENROLLING_BY_INVITATIONThis study investigates whether a blood test can detect the bacteria that cause tuberculosis (TB) in people with active TB and their asymptomatic household contacts. Researchers in Uganda will use several methods, including a DNA-based test, to look for TB bacteria in blood sampl…
Matched conditions: LATENT TUBERCULOSIS
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC